Zentalis Pharmaceuticalsllc Stock Filter Stocks by Fundamentals
| ZNTL Stock | USD 12.57 0.43 3.31% |
Zentalis PharmaceuticalsLlc fundamentals help investors to digest information that contributes to Zentalis PharmaceuticalsL's financial success or failures. It also enables traders to predict the movement of Zentalis Stock. The fundamental analysis module provides a way to measure Zentalis PharmaceuticalsL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zentalis PharmaceuticalsL stock.
Zentalis | Shares Owned by Institutions |
Zentalis PharmaceuticalsL Institutional Holders
Institutional Holdings refers to the ownership stake in Zentalis PharmaceuticalsL that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zentalis PharmaceuticalsL's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zentalis PharmaceuticalsL's value.| Shares | Decheng Capital Llc | 2023-12-31 | 2.1 M | Woodline Partners Lp | 2023-12-31 | 1.4 M | Geode Capital Management, Llc | 2023-12-31 | 1.3 M | Primecap Management Company | 2023-12-31 | 1 M | Tybourne Capital Management (hk) Ltd | 2023-12-31 | 961.5 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 724 K | Bank Of America Corp | 2023-12-31 | 718.6 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 609.5 K | Goldman Sachs Group Inc | 2023-12-31 | 585.8 K | Matrix Capital Management Company, Llc | 2023-12-31 | 14 M | Eventide Asset Management, Llc | 2023-12-31 | 11.6 M |
Zentalis Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 485.44 M | ||||
| Shares Outstanding | 70.96 M | ||||
| Shares Owned By Insiders | 4.27 % | ||||
| Shares Owned By Institutions | 95.73 % | ||||
| Number Of Shares Shorted | 15.53 M | ||||
| Price To Book | 2.18 X | ||||
| EBITDA | (252.55 M) | ||||
| Net Income | (292.19 M) | ||||
| Cash And Equivalents | 455.22 M | ||||
| Cash Per Share | 7.99 X | ||||
| Total Debt | 45.77 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 9.61 X | ||||
| Book Value Per Share | 6.18 X | ||||
| Cash Flow From Operations | (207.82 M) | ||||
| Short Ratio | 16.26 X | ||||
| Earnings Per Share | (4.47) X | ||||
| Target Price | 34.4 | ||||
| Number Of Employees | 124 | ||||
| Beta | 1.73 | ||||
| Market Capitalization | 922.48 M | ||||
| Total Asset | 562.03 M | ||||
| Retained Earnings | (888.56 M) | ||||
| Working Capital | 427.35 M | ||||
| Net Asset | 562.03 M |
About Zentalis PharmaceuticalsL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zentalis PharmaceuticalsLlc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zentalis PharmaceuticalsL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:Check out Zentalis PharmaceuticalsL Piotroski F Score and Zentalis PharmaceuticalsL Altman Z Score analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.